Financial insights of MDCXW

General and administrative expense

6,571,097

5,892,684

28,838,537.75*

-

Research and development expense

4,907,692

2,704,393

3,402,744*

-

Research and development expense (excluding acquired in process cost)

-

2,179,368.75*

-

Operating expenses

11,478,789

8,597,077

34,420,650.5

-

Loss from operations

-11,478,789

-8,597,077

-34,420,650.5*

-

Finance (income) expense, net

0

56,561

-

Finance income

-

-545,284.5*

-

Interest (expense)

205,638

374,712

-

Represents the amount of gain loss on settlements

0

-127,083

-69,713.5*

-

Represents the amount if change in fair value of debentures

0

-

16,177*

-

Repayment of debentures on extinguishment

-

-6,250*

-

Total other income

-205,638

-445,234

-605,071*

-

Net loss for the period

-11,684,427

-9,042,311

-35,025,721.5*

-

Deemed dividend on warrant inducement

-

2,959,324.5*

-

Net income (loss) available to common stockholders, basic

-

-9,042,311

-37,985,046*

-

Foreign exchange gain/loss

255,177

-204,249

-43,214*

10,828

Comprehensive income (loss), net of tax, attributable to parent

-

-9,246,560

-38,028,260

-2

Comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest

-11,429,250

-

Basic EPS

-0.21

-0.31

-2.008

-1.12

Diluted EPS

-0.21

-0.31

-2.008

-1.12

Basic Average Shares

55,055,225

29,540,833

18,935,543

18,631,668

Diluted Average Shares

55,055,225

29,540,833

18,935,543

18,631,668

MyFinsight

Income Overview

Time Plot

Income Statement

Income Overview

Time Plot

Income Statement